Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro

BACKGROUND: Despite clinical success with anti-spike vaccines, the effectiveness of neutralizing antibodies and vaccines has been compromised by rapidly spreading SARS-CoV-2 variants. Viruses can hijack the glycosylation machinery of host cells to shield themselves from the host's immune respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hsiang-Chi, Lai, Yun-Ju, Liao, Chun-Che, Yang, Wang-Feng, Huang, Ke-Bin, Lee, I-Jung, Chou, Wen-Cheng, Wang, Shih-Han, Wang, Ling-Hui, Hsu, Jung-Mao, Sun, Cheng-Pu, Kuo, Chun-Tse, Wang, Jyun, Hsiao, Tzu-Chun, Yang, Po-Jiun, Lee, Te-An, Huang, Wilson, Li, Fu-An, Shen, Chen-Yang, Lin, Yi-Ling, Tao, Mi-Hua, Li, Chia-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613501/
https://www.ncbi.nlm.nih.gov/pubmed/34839261
http://dx.doi.org/10.1016/j.ebiom.2021.103712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613501/
https://www.ncbi.nlm.nih.gov/pubmed/34839261
http://dx.doi.org/10.1016/j.ebiom.2021.103712

Ejemplares similares